This Article Full Text Full Text (PDF) All Versions of this Article: 38/2/431    most recent 01.STR.0000254524.23708.c9v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khatri, P. Articles by Broderick, J. P. Search for Related Content PubMed PubMed Citation Articles by Khatri, P. Articles by Broderick, J. P. Related Collections Thrombolysis Other Stroke Treatment - Medical Other Stroke Treatment - Surgical Acute Cerebral Infarction Emergency treatment of Stroke Intracerebral Hemorrhage

(Stroke. 2007;38:431.)
© 2007 American Heart Association, Inc.

Progress Reviews

Intracranial Hemorrhage Associated With Revascularization Therapies

From University of Cincinnati (P.K., J.P.B.), Department of Neurology, Cincinnati, Ohio; and the University of Pittsburgh (L.R.W.), Pa.

Correspondence to Pooja Khatri, MD, University of Cincinnati, Department of Neurology, 231 Albert Sabin Way ML 0525, Cincinnati, OH 45267-0525. E-mail pooja.khatri{at}uc.edu

Background and Purpose— This review discusses the state of our current knowledge on hemorrhagic transformation (HT) and summarizes key factors to be considered when comparing risk associated with various approaches to revascularization.

Summary of Review— HT is a common and natural consequence of infarction, likely related to matrix metalloproteinases and free radical pathways disrupting permeability barriers between blood and brain during ischemia and reperfusion. Symptomatic HT rates within 24 to 36 hours of stroke are increased in the setting of revascularization therapy regardless of modality. HT incidence rates must be considered in the context of the timing of imaging, the period of the study, the definition of clinically significant HT, and other key predictors of HT. The most consistently identified predictors of clinically significant HT in acute revascularization trials have been thrombolytic therapy, dose of lytic agents, edema or mass effect on head CT, stroke severity, and age. Other risk factors may be hyperglycemia, concurrent heparin use, timing of therapy, and timing of successful recanalization. Future predictors may also include imaging parameters, serological markers, variables related to intra-arterial technique, and arterial lesion location.

Conclusions— Understanding how baseline and treatment variables impact HT rates after acute stroke is critical for those designing and interpreting acute stroke trials. Future trials should consider the use of PH-2 as a standardized safety end point, putting hemorrhagic changes in the context of overall clinical outcome, and developing strategies to reduce the rates of clinically significant intracranial hemorrhage.

Key Words: stroke • ischemia • reperfusion • thrombolysis • endovascular treatment • intracranial hemorrhage

This article has been cited by other articles:

				P. Khatri, R. A. Taylor, V. Palumbo, V. Rajajee, J. M. Katz, J. A. Chalela, A. Geers, J. Haymore, D. M. Kolansky, S. E. Kasner, et al. The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 906 - 911. [Abstract] [Full Text] [PDF]

				H. B. van der Worp and J. van Gijn Acute Ischemic Stroke N. Engl. J. Med., August 9, 2007; 357(6): 572 - 579. [Full Text] [PDF]

				J. L. Saver Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm Stroke, August 1, 2007; 38(8): 2279 - 2283. [Abstract] [Full Text] [PDF]

				B. M. Demaerschalk Thrombolytic Therapy for Acute Ischemic Stroke: The Likelihood of Being Helped Versus Harmed Stroke, August 1, 2007; 38(8): 2215 - 2216. [Full Text] [PDF]